TARRYTOWN, N.Y., Sept. 26 /PRNewswire-USNewswire/ -- The National Alliance for Thrombosis and Thrombophilia (NATT) today announced the award of two major program grants totaling $1.35 million that will serve as building blocks for its efforts to curb the unchecked devastating effects caused each year to nearly one million Americans who develop a blood clot.
NATT will use its two Centers for Disease Control and Prevention (CDC) grants to "launch a national wake-up call to promote public and healthcare professional awareness of this serious medical condition that each year kills nearly 300,000 Americans," explains NATT President Randy Fenninger.
"We have a national crisis because few people recognize or understand the symptoms and risk factors of this silent killer. And even equally startling, is that not enough of our nation's healthcare professionals have a full understanding of the symptoms and the methods for treatment of this life- threatening condition," he said. Complications from clotting, occurring in more than half of those affected individuals, can often have serious consequences - as is evident from an annual mortality rate that is greater than the combined deaths from breast cancer, AIDS, and automobile accidents.
Mr. Fenninger complimented the proactive efforts of the CDC for recognizing the need to fund an all-out public and professional attack against blood clotting disorders. The awards, he notes, "serve to further support our national education and awareness work. This is a superb news for all Americans at risk for blood clots, and a very proud moment for the many volunteers who have worked so hard to move NATT from a board room dream to a now nationally respected community-based advocacy organization that does so much good."
Aiding the CDC's proactive funding efforts was a meeting held in May of
2006 by the U.S. Surgeon General who brought together national healthcare
and public leaders to discuss the serious problems
|SOURCE National Alliance for Thrombosis and Thrombophilia|
Copyright©2007 PR Newswire.
All rights reserved